Ignite Creation Date:
2024-05-05 @ 5:17 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00420836
Status:
COMPLETED
Last Update Posted:
2007-01-11
First Post:
2007-01-10
Brief Title:
Tobramycin Administered by eFlow Rapid Nebulizer Pharmacokinetic Study
Sponsor:
Novartis
Organization:
Novartis
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Cystic Fibrosis |
Keywords:
| Name | View |
|---|---|
| Cystic fibrosis tobramycin PARI eFlow PARI LC Plus nebulizer pharmacokinetic | View |